Andy Zöllner

525 total citations
17 papers, 442 citations indexed

About

Andy Zöllner is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Andy Zöllner has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Andy Zöllner's work include Pharmacogenetics and Drug Metabolism (13 papers), Hormonal Regulation and Hypertension (10 papers) and Hormonal and reproductive studies (6 papers). Andy Zöllner is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Hormonal Regulation and Hypertension (10 papers) and Hormonal and reproductive studies (6 papers). Andy Zöllner collaborates with scholars based in Germany, United States and Spain. Andy Zöllner's co-authors include Rita Bernhardt, Matthias Bureik, Frank Hannemann, Frank T. Peters, Hans H. Maurer, Burkhard Schiffler, Călin-Aurel Drăgan, Michael Lisurek, Nils E. Schlörer and Maria Kristina Parr and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Andy Zöllner

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Zöllner Germany 14 259 232 138 43 43 17 442
Satya Prakash Panda United States 18 208 0.8× 247 1.1× 61 0.4× 109 2.5× 48 1.1× 31 803
Călin-Aurel Drăgan Germany 13 247 1.0× 228 1.0× 95 0.7× 48 1.1× 40 0.9× 14 409
Michael C. Gregory United States 11 296 1.1× 257 1.1× 148 1.1× 64 1.5× 13 0.3× 15 552
I. I. Karuzina Russia 14 189 0.7× 298 1.3× 23 0.2× 50 1.2× 42 1.0× 51 542
Atsuo Hiwatashi Japan 17 310 1.2× 356 1.5× 289 2.1× 45 1.0× 80 1.9× 34 774
Г.П. Кузнецова Russia 12 234 0.9× 202 0.9× 31 0.2× 77 1.8× 19 0.4× 26 469
David J. St. Jean United States 16 65 0.3× 258 1.1× 113 0.8× 44 1.0× 33 0.8× 28 751
Sabrina Hoebenreich Germany 8 106 0.4× 364 1.6× 20 0.1× 24 0.6× 18 0.4× 10 483
Peter Lee-Robichaud United Kingdom 10 330 1.3× 214 0.9× 268 1.9× 63 1.5× 11 0.3× 11 542
David W. Seybert United States 15 360 1.4× 551 2.4× 285 2.1× 58 1.3× 74 1.7× 21 945

Countries citing papers authored by Andy Zöllner

Since Specialization
Citations

This map shows the geographic impact of Andy Zöllner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Zöllner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Zöllner more than expected).

Fields of papers citing papers by Andy Zöllner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Zöllner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Zöllner. The network helps show where Andy Zöllner may publish in the future.

Co-authorship network of co-authors of Andy Zöllner

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Zöllner. A scholar is included among the top collaborators of Andy Zöllner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Zöllner. Andy Zöllner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Qi, Yan, David Machalz, Andy Zöllner, et al.. (2017). Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast. Biochemical Pharmacology. 146. 174–187. 41 indexed citations
2.
Parr, Maria Kristina, Andy Zöllner, Gregor Fußhöller, et al.. (2012). Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination – Insights from metandienone metabolism. Toxicology Letters. 213(3). 381–391. 35 indexed citations
3.
Schiffler, Burkhard, Andy Zöllner, & Rita Bernhardt. (2011). Kinetic and optical biosensor study of adrenodoxin mutant AdxS112W displaying an enhanced interaction towards the cholesterol side chain cleavage enzyme (CYP11A1). European Biophysics Journal. 40(12). 1275–1282. 5 indexed citations
4.
Naumann, Julia, et al.. (2011). Biotechnological Production of 20-alpha-Dihydrodydrogesterone at Pilot Scale. Applied Biochemistry and Biotechnology. 165(1). 190–203. 13 indexed citations
5.
Zöllner, Andy, et al.. (2010). Substitution of lysine with glutamic acid at position 193 in bovine CYP11A1 significantly affects protein oligomerization and solubility but not enzymatic activity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1814(1). 126–131. 14 indexed citations
6.
Zöllner, Andy, et al.. (2010). Atomic Force Microscopy Study of Protein–Protein Interactions in the Cytochrome CYP11A1 (P450scc)-Containing Steroid Hydroxylase System. Nanoscale Research Letters. 6(1). 54–54. 32 indexed citations
7.
Zöllner, Andy, et al.. (2010). Production of Human Phase 1 and 2 Metabolites by Whole-Cell Biotransformation with Recombinant Microbes. Bioanalysis. 2(7). 1277–1290. 36 indexed citations
8.
Zöllner, Andy, Maria Kristina Parr, Călin-Aurel Drăgan, et al.. (2009). CYP21-catalyzed production of the long-term urinary metandienone metabolite 17β-hydroxymethyl-17α-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping. Biological Chemistry. 391(1). 119–27. 32 indexed citations
9.
Hannemann, Frank, et al.. (2009). The dipole moment of the electron carrier adrenodoxin is not critical for redox partner interaction and electron transfer. Journal of Inorganic Biochemistry. 103(7). 997–1004. 14 indexed citations
10.
Zöllner, Andy, Michael Lisurek, Adrián Velázquez‐Campoy, et al.. (2009). Cyanobacterial electron carrier proteins as electron donors to CYP106A2 from Bacillus megaterium ATCC 13368. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(11). 1635–1642. 17 indexed citations
11.
Zöllner, Andy, Norio Kagawa, Michael R. Waterman, et al.. (2008). Purification and functional characterization of human 11β hydroxylase expressed in Escherichia coli. FEBS Journal. 275(4). 799–810. 46 indexed citations
12.
Zöllner, Andy, Călin-Aurel Drăgan, Dominik Pistorius, et al.. (2008). Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. Biological Chemistry. 390(4). 313–317. 49 indexed citations
13.
Zöllner, Andy, Melissa A. Pasquinelli, Rita Bernhardt, & David N. Beratan. (2007). Protein Phosphorylation and Intermolecular Electron Transfer:  A Joint Experimental and Computational Study of a Hormone Biosynthesis Pathway. Journal of the American Chemical Society. 129(14). 4206–4216. 19 indexed citations
14.
Bureik, Matthias, Andy Zöllner, Norbert Schuster, Mathias Montenarh, & Rita Bernhardt. (2005). Phosphorylation of Bovine Adrenodoxin by Protein Kinase CK2 Affects the Interaction with Its Redox Partner Cytochrome P450scc (CYP11A1). Biochemistry. 44(10). 3821–3830. 19 indexed citations
15.
Schiffler, Burkhard, Andy Zöllner, & Rita Bernhardt. (2004). Stripping Down the Mitochondrial Cholesterol Hydroxylase System, a Kinetics Study. Journal of Biological Chemistry. 279(33). 34269–34276. 33 indexed citations
16.
17.
Zöllner, Andy, Frank Hannemann, Michael Lisurek, & Rita Bernhardt. (2002). Deletions in the loop surrounding the iron–sulfur cluster of adrenodoxin severely affect the interactions with its native redox partners adrenodoxin reductase and cytochrome P450scc (CYP11A1). Journal of Inorganic Biochemistry. 91(4). 644–654. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satya Prakash Panda Breakdown of academic impact, for papers by Călin-Aurel Drăgan Breakdown of academic impact, for papers by Michael C. Gregory Breakdown of academic impact, for papers by I. I. Karuzina Breakdown of academic impact, for papers by Atsuo Hiwatashi Breakdown of academic impact, for papers by Г.П. Кузнецова Breakdown of academic impact, for papers by David J. St. Jean Breakdown of academic impact, for papers by Sabrina Hoebenreich Breakdown of academic impact, for papers by Peter Lee-Robichaud Breakdown of academic impact, for papers by David W. Seybert
Rankless by CCL
2026